Doxorubicin Hydrochloride Injection, Solution
Product Images NDC 0069-3358

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 0069-3358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Doxorubicin 01)

Chemical structure of doxorubicin hydrochloride showing the molecular formula C27H29NO11 with an HCl component and molecular weight of 579.99.*

FDA Label Image

Figure 1 (Doxorubicin 02)

A forest plot showing hazard ratios with 95% confidence intervals from multiple clinical trials comparing Doxorubicin Hydrochloride (Doxo) to CMF treatment. Trials include NSABP B-15, SECSG 2, ONCOFRANCE, SE Sweden BCG A, NSABC Israel Br0283, and Austrian BCSG 3. The plot illustrates whether Doxo is better or worse than CMF, with a boundary of non-inferiority marked at 1.06.*

FDA Label Image

Figure 2 (Doxorubicin 03)

A forest plot showing hazard ratios with 95% confidence intervals for six trials comparing Doxorubicin-based treatments to CMF. The horizontal axis ranges from 0.0 to 2.0, indicating whether Doxorubicin is better or worse than CMF. Individual trial results are represented by squares and horizontal lines, with an overall summary diamond displayed below.*

FDA Label Image

Premierpro Logo (Doxorubicin 04)

FDA Label Image

Principal Display Panel (10 mg/5 mL Vial Label)

FDA Label Image

Principal Display Panel (10 mg/5 mL Vial Carton)

Label for Doxorubicin Hydrochloride Injection 10 mg/5 mL (2 mg/mL) by Pfizer Laboratories Division of Pfizer Inc. It is a single-dose sterile isotonic solution in a Cytosafe vial for intravenous use only. The label includes storage instructions to refrigerate between 2 and 8°C and cautions that the product is a cytotoxic agent. The label also notes it is made in Australia.*

FDA Label Image

Principal Display Panel (20 mg/10 mL Vial Label)

Packaging label for Doxorubicin Hydrochloride Injection 10 mg/5 mL (2 mg/mL) by Pfizer Laboratories. The label indicates a single-dose vial for intravenous use only, with a cytotoxic caution. It includes storage instructions to keep refrigerated between 2° and 8°C and advises discarding any unused portion. The label also notes that the product is made in Australia and distributed by Pfizer Labs, Division of Pfizer Inc.*

FDA Label Image

Principal Display Panel (20 mg/10 mL Vial Carton)

Label for Doxorubicin Hydrochloride Injection, 2 mg/mL strength, in a 10 mL vial. The label states it is a sterile, isotonic solution for intravenous use only and includes handling instructions such as storage refrigeration between 2° and 8°C and protection from light. It is a cytotoxic agent labeled as single-dose with Rx only. Manufactured in Australia and distributed by Pfizer Laboratories Div Pfizer Inc.*

FDA Label Image

Principal Display Panel (50 mg/25 mL Vial Label)

Packaging label for Doxorubicin Hydrochloride Injection 20 mg/10 mL (2 mg/mL) by Pfizer Laboratories. The single-dose vial label states it is for intravenous use only, with a caution for cytotoxicity. Storage instructions indicate refrigeration between 2 and 8 degrees Celsius, and it is marked for Rx only.*

FDA Label Image

Principal Display Panel (50 mg/25 mL Vial Carton)

Doxorubicin Hydrochloride Injection label showing 50 mg/25 mL (2 mg/mL) sterile, isotonic solution in a single-dose vial. For intravenous use only, cytotoxic agent warning included. Distributed by Pfizer Labs, the label instructs refrigeration between 2° and 8°C and protection from light. The product is made in Australia and marked as Rx only.*

FDA Label Image

Principal Display Panel (200 mg/100 mL Vial Label)

Packaging label for Doxorubicin Hydrochloride Injection, 50 mg/25 mL (2 mg/mL), a cytotoxic agent for intravenous use in a Cytosafe vial. The label includes storage instructions, dosage information, barcode, lot and expiration data, and manufacturer details citing distribution by Pfizer Labs, division of Pfizer Inc.*

FDA Label Image

Principal Display Panel (200 mg/100 mL Vial Carton)

Label for Doxorubicin Hydrochloride Injection 2 mg/mL (200 mg/100 mL) in a multiple-dose vial. The label indicates the product is for intravenous use only, is cytotoxic, and should be stored refrigerated between 2° and 8°C. It is labeled as a sterile, isotonic solution distributed by Pfizer Laboratories Division of Pfizer Inc, made in Australia.*

FDA Label Image

Doxorubicin 13

Packaging label for Doxorubicin Hydrochloride Injection 200 mg/100 mL (2 mg/mL) multiple-dose vial by Pfizer Laboratories. The sterile, isotonic solution is for intravenous use only. The label includes storage instructions, dosage information, and a caution noting it is a cytotoxic agent. The product is made in Australia and distributed by Pfizer Labs Division of Pfizer Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.